Yuflyma is a biosimilar to Humira, biosimilars are biologic medicines that are a very close copy to the original product made by another company. It is not an interchangeable biosimilar. Yuflyma is available as a high-concentration and citrate-free formulation and can be given using a prefill...
韩国生物制药巨头Celltrion近日宣布，欧盟委员会（EC）已批准Yuflyma（CT-P17，阿达木单抗生物类似药），该药是艾伯维（AbbVie）超重磅产品Humira（修美乐，通用名：adalimumab，阿达木单抗）的生物类似药。此次批准，涵盖治疗多种慢性炎症性疾病的所有预期13个适应症。值得一提的是，Yuflyma是第一款高浓度、低容量...
Yuflyma(CT-P17)Adalimumab(阿达木单抗)是艾伯维(AbbVie)的Humira(ada … 继续阅读进展|Yuflyma(阿达木单抗)生物类似药欧盟获批13个适应症 百配健康-阅读越健康! 0条评论
In May 2023, FDA approved Yuflyma [1], the ninth biosimilar for Adalimumab (Humira), to treat various inflammatory diseases including juvenile idiopathic arthritis (JIA), hidradeni-tis suppurativa, Crohn's disease (CD), plaque psoriasis (PP), ankylosing spondylitis (AnS), rheumatoid arthritis (...
Yuflyma (adalimumab-aaty) is a tumor necrosis factor (TNF) blocker indicated for: reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis (RA...
“The launch of Yuflyma is a critical milestone not only for Celltrion USA, but for patients, healthcare providers, and payers,” said Tom Nusbickel, Chief Commercial Officer at Celltrion USA. “We are committed to providing a patient-centric approach with a focus on increased a...
Celltrion said Tuesday that U.S. retailer Costco has begun selling its Humira biosimilar Yuflyma Low WAC (adalimumab).Earlier this month, Celltrion completed enrollment of the low wholesale acquisition cost (Low WAC) version of Yuflyma in the Costco Memb
The US Food and Drug Administration (FDA) has approved the biosimilar adalimumab-aaty (Yuflyma) in a citrate-free, high-concentration formulation, the manufacturer, Celltrion USA,announced today. It is the ninth biosimilar ofadalimumab(Humira) to be approved in the United States. ...
Celltrion USA has received approval from the US Food and Drug Administration (FDA) for Yuflyma (adalimumab-aaty) for multiple indications.
回复@汤面毛豆宝宝: 最后用了阿达木,不过我人在国外,用的是celltrion产的仿制药yuflyma(国内现在一般压不住也都是直接推生物制剂了,IBD用生物制剂很常见了),配合我自己饮食控制,生物制剂效果很快。氨基水杨酸几乎没有用约等于安慰剂,只有对非常轻的有用。皮质醇只能短期用来紧急过渡压炎症的,我等药期间用过,激素...